×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AYTU – aytu biopharma, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AYTU
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/22
09:14 am
aytu
Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM) [Yahoo! Finance]
Medium
Report
Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM) [Yahoo! Finance]
11/22
09:00 am
aytu
Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)
Medium
Report
Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)
11/14
02:31 am
aytu
Aytu BioPharma Inc (AYTU) Q1 2025 Earnings Call Highlights: A Historic Quarter with Positive ... [Yahoo! Finance]
High
Report
Aytu BioPharma Inc (AYTU) Q1 2025 Earnings Call Highlights: A Historic Quarter with Positive ... [Yahoo! Finance]
11/13
07:28 pm
aytu
Aytu BioPharma, Inc. (AYTU) Q1 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
Aytu BioPharma, Inc. (AYTU) Q1 2025 Earnings Call Transcript [Seeking Alpha]
11/13
04:22 pm
aytu
Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results [Yahoo! Finance]
High
Report
Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results [Yahoo! Finance]
11/13
04:05 pm
aytu
Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results
High
Report
Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results
11/6
05:28 pm
aytu
Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024 [Yahoo! Finance]
Medium
Report
Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024 [Yahoo! Finance]
11/6
05:20 pm
aytu
Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024
Medium
Report
Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/13
05:37 pm
aytu
Form SC 13G/A AYTU BIOPHARMA, INC Filed by: Stonepine Capital Management, LLC
High
Report
Form SC 13G/A AYTU BIOPHARMA, INC Filed by: Stonepine Capital Management, LLC
11/13
05:21 pm
aytu
Form 10-Q AYTU BIOPHARMA, INC For: Sep 30
High
Report
Form 10-Q AYTU BIOPHARMA, INC For: Sep 30
11/13
04:11 pm
aytu
Form 4 AYTU BIOPHARMA, INC For: Nov 11 Filed by: Selhorn Ryan J
High
Report
Form 4 AYTU BIOPHARMA, INC For: Nov 11 Filed by: Selhorn Ryan J
11/13
04:09 pm
aytu
Form 3 AYTU BIOPHARMA, INC For: Nov 11 Filed by: Selhorn Ryan J
High
Report
Form 3 AYTU BIOPHARMA, INC For: Nov 11 Filed by: Selhorn Ryan J
11/13
04:07 pm
aytu
Form 8-K AYTU BIOPHARMA, INC For: Nov 11
High
Report
Form 8-K AYTU BIOPHARMA, INC For: Nov 11
11/8
08:45 pm
aytu
Form 4 AYTU BIOPHARMA, INC For: Nov 06 Filed by: DOCKERY CARL
Medium
Report
Form 4 AYTU BIOPHARMA, INC For: Nov 06 Filed by: DOCKERY CARL
11/8
08:35 pm
aytu
Form 4 AYTU BIOPHARMA, INC For: Nov 06 Filed by: Donofrio John Jr.
Medium
Report
Form 4 AYTU BIOPHARMA, INC For: Nov 06 Filed by: Donofrio John Jr.
11/8
08:28 pm
aytu
Form 4 AYTU BIOPHARMA, INC For: Nov 06 Filed by: JAIN ABHINAV
Medium
Report
Form 4 AYTU BIOPHARMA, INC For: Nov 06 Filed by: JAIN ABHINAV
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/10
Aytu BioScience Secures Exclusive U.S. Distribution Agreement for Coronavirus 2019 (COVID-19) Point-of-Care Rapid Test
489.1%
3/13 Form 8-K AYTU BIOSCIENCE, INC For: Mar 12 39.8%
3/20 Form 424B5 AYTU BIOSCIENCE, INC 38.5%
6/4 Aytu BioScience Announces Exclusive Distribution Agreement with Beijing Dahua Sanxin Technology Development Co., Ltd. to Commercialize MiOXSYS(R) Male Infertility Test in China 16.7%
3/12 Form SC 13G AYTU BIOSCIENCE, INC Filed by: SABBY MANAGEMENT, LLC 16.5%
11/19 Aytu BioScience Announces Addition of Tuzistra(R) XR to Leading Pharmacy Benefit Manager’s National Formulary 15.9%
12/11 Form 425 AYTU BIOSCIENCE, INC Filed by: AYTU BIOSCIENCE, INC 14.7%
12/23 Form DEF 14A AYTU BIOSCIENCE, INC For: Jan 24 12.9%
4/30 Aytu BioScience Announces China Export Clearance of Company's COVID-19 IgG/IgM Rapid Test 9.3%
10/16 Aytu BioScience to Announce Results from Natesto(R) Spermatogenesis Study on Thursday, October 17 8.9%
3/13 Form 8-K AYTU BIOSCIENCE, INC For: Mar 12 39.8%
3/20 Form 424B5 AYTU BIOSCIENCE, INC 38.5%
6/4 Aytu BioScience Announces Exclusive Distribution Agreement with Beijing Dahua Sanxin Technology Development Co., Ltd. to Commercialize MiOXSYS(R) Male Infertility Test in China 16.7%
3/12 Form SC 13G AYTU BIOSCIENCE, INC Filed by: SABBY MANAGEMENT, LLC 16.5%
11/19 Aytu BioScience Announces Addition of Tuzistra(R) XR to Leading Pharmacy Benefit Manager’s National Formulary 15.9%
12/11 Form 425 AYTU BIOSCIENCE, INC Filed by: AYTU BIOSCIENCE, INC 14.7%
12/23 Form DEF 14A AYTU BIOSCIENCE, INC For: Jan 24 12.9%
4/30 Aytu BioScience Announces China Export Clearance of Company's COVID-19 IgG/IgM Rapid Test 9.3%
10/16 Aytu BioScience to Announce Results from Natesto(R) Spermatogenesis Study on Thursday, October 17 8.9%
TOP News Decliners
3/11
Aytu Announces $9.0 Million Registered Direct Offering Priced At-the-Market
-45.6%
3/12 Form 8-K AYTU BIOSCIENCE, INC For: Mar 09 -36.1%
3/19 Form 8-K AYTU BIOSCIENCE, INC For: Mar 13 -27.0%
9/26 Aytu BioScience EPS misses by $1.33, misses on revenue [Seeking Alpha] -19.1%
11/14 Form 8-K AYTU BIOSCIENCE, INC For: Nov 14 -18.6%
4/23 Aytu BioScience Announces Exclusive Distribution Agreement for COVID-19 IgG/IgM Rapid Test with Singapore-Based Biolidics Limited -15.6%
3/30 AYTU Announces Delay of Annual Meeting of Stockholders Due to Colorado's "Shelter in Place" Order Related to the COVID-19 Crisis -15.2%
4/21 INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Aytu BioScience, Inc. (AYTU) on Behalf of Investors -15.1%
2/13 Aytu BioScience's (AYTU) CEO Josh Disbrow on Q2 2020 Results - Earnings Call Transcript [Seeking Alpha] -14.5%
4/1 Form 8-K AYTU BIOSCIENCE, INC For: Mar 31 -13.1%
3/12 Form 8-K AYTU BIOSCIENCE, INC For: Mar 09 -36.1%
3/19 Form 8-K AYTU BIOSCIENCE, INC For: Mar 13 -27.0%
9/26 Aytu BioScience EPS misses by $1.33, misses on revenue [Seeking Alpha] -19.1%
11/14 Form 8-K AYTU BIOSCIENCE, INC For: Nov 14 -18.6%
4/23 Aytu BioScience Announces Exclusive Distribution Agreement for COVID-19 IgG/IgM Rapid Test with Singapore-Based Biolidics Limited -15.6%
3/30 AYTU Announces Delay of Annual Meeting of Stockholders Due to Colorado's "Shelter in Place" Order Related to the COVID-19 Crisis -15.2%
4/21 INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Aytu BioScience, Inc. (AYTU) on Behalf of Investors -15.1%
2/13 Aytu BioScience's (AYTU) CEO Josh Disbrow on Q2 2020 Results - Earnings Call Transcript [Seeking Alpha] -14.5%
4/1 Form 8-K AYTU BIOSCIENCE, INC For: Mar 31 -13.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: